NucMedResource.com
  • Home
  • Radiology
  • Blog
  • Favorite Books
  • Pulmonary NM ("V/Q")
  • Endocrinology NM
    • Benign Thyroid Disease
    • Thyroid Cancer
    • Parathyroid Scan
  • Neurology NM
    • Brain Death Scan
    • DaT Scan
  • Neurology PET
  • Oncology NM
    • MIBG
    • OctreoScan
    • ProstaScint
  • Oncology PET
    • Normal FDG PET Oncology
    • PET Lung Cancer
    • FDG PET Pitfalls
  • Cardiology NM
    • EKG
    • MP SPECT
  • Cardiology PET
  • GI
    • Hepatobiliary "HIDA" Scan
    • Gastric Emptying
  • Bones
  • Infection & Inflammation
    • WBC Scan
    • Gallium Scan
  • Other General NM
  • Lymph Node Stations
    • H&N Nodal Stations
    • Thoracic Nodal Stations
    • Abdominal Nodal Stations
  • Protocols
  • Presentations
  • Reading Material
  • Exposures

Thyroid Cancer Imaging - I-123/I-131 Planar & SPECT/CT and F-18 FDG PET/CT


Patient Preparation

Recommended withdrawal times for various medications before diagnostic imaging or therapy with radioactive iodine is described below. (Click below to enlarge the table.) 
Picture

Well-Differentiated Thyroid Cancer

Backlog

Razfar A et al. Clinical Usefulness of Positron Emission Tomography–Computed Tomography in Recurrent Thyroid Carcinoma. Arch Otolaryngol Head Neck Surg. 2010;136(2):120-125. (AOHNS link)

Shammas A et al. 18F-FDG PET/CT in Patients with Suspected Recurrent or Metastatic Well-Differentiated Thyroid Cancer. J Nucl Med 2007; 48(2): 221-226. (
JNM link)

Management (DTC)

Society of Nuclear Medicine Procedure Guideline for Scintigraphy for Differentiated Papillary and Follicular Thyroid Cancer. SNM. 

Therapy (DTC)

Society of Nuclear Medicine Procedure Guideline for Therapy of Thyroid Disease with Iodine-131 (Sodium Iodide). Version 2.0. SNM.  

Medullary Thyroid Cancer

Backlog

Ong SC et al. Diagnostic Accuracy of 18F-FDG PET in Restaging Patients with Medullary Thyroid Carcinoma and Elevated Calcitonin Levels. J Nucl Med 2001; 42(1): 77-78. (JNM link)

Notes

According to recent NEJM articles, Thyrogen as a preparation for iodine uptake is "non-inferior" to TH Withdrawal (THW) for Stage I and II DTC. There is not enough data to say this for Stage III and IV DTC, so THW is the preferred method of preparation.
- SM at Endocrinology MDTB 7/2014
This site is educational in nature and for nuclear medicine, radiology and medical professionals in the U.S., contains user contributed content, and material that may be confusing to a lay audience. Readers are asked to check the most current information on nuclear medicine techniques as this website may not be all-encompassing or up-to-date. It is solely the responsibility of the professional to practice nuclear medicine based on his or her experience and knowledge of the patient. To the fullest extent of the law, neither the publisher or authors assume any liability for any consequences to persons or property arising out of or related to any use of the material in this website.